UNSPSC 51332872: Propiomazine hydrochloride

This classification denotes an antipsychotic agent with the molecular formula C20H24N2OS.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 70BO17YR03, chemically known as 1-propanone, 1-(10-(2-(dimethylamino)propyl)-10h-phenothiazin-2-yl)-, monohydrochloride but more generally known as propiomazine hydrochloride, which bears US NIH Compound Identifier 71802. European Medicines Agency schedules Propiomazine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04083MIG.

UNSPSC 51332872 Propiomazine hydrochloride is a Commodity code with minimal recent activity in state and local procurement. The single recent opportunity posted under this code—Seminole County, Florida's IFB 60459723LAS in June 2026—solicits naloxone and safe drug deactivation systems, not propiomazine hydrochloride specifically. This mismatch between the code's nominal scope and the actual procurement suggests the code does not reflect current state and local buying patterns for this pharmaceutical product. The opportunity itself is driven by community health initiatives and requires quarterly deliveries with electronic bidding through the county's e-Procurement Portal, two-year contract terms with optional one-year renewal, and standard compliance requirements including E-Verify and drug-free workplace certification.

No other recent state and local opportunities appear in the available records under this code. Geographic activity is limited to Florida based on the single Seminole County solicitation. Bidders responding to the Seminole County IFB faced a July 26, 2023 response deadline (note: the posting date of June 30, 2026 appears inconsistent with the bid deadline cited in the opportunity details). Given the sparse and potentially misclassified activity, propiomazine hydrochloride procurement does not present a clear target for pursuit at the state and local level under this code at this time.